title: FPIN's clinical inquiries. Cardiovascular risk of combined oral contraceptive use.
authors: New Hanover Regional Medical Center Family Medicine Residency, Wilmington, NC, USA. adfehrfp@gmail.com
authors: Adrienne D
authors: AD
authors: Fehr
authors: Anne
authors: A
authors: Mounsey
authors: Jennifer E
authors: JE
authors: Yates
authors: Donna
authors: D
authors: Flake
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000009:adverse effects*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D020521:Stroke / Q000139:chemically induced
chemical_list: D003277:Contraceptives, Oral, Combined